Yue et al. found out that MSX1 has tumor-suppressive functions by inducing apoptosis and cell cycle arrest in breast cancer tumorigenesis, so they postulate that a methylation of MSX1 can be used a biomarker for early diagnosis and detection of breast cancer [25]. This evidence concerns the gene MSX1 and breast cancer.